Perform Another (Advanced) Search

1.  Study Posting (2246) Trial #94827, Prostate Cancer, Duarte, CA
...Study Posting (2246) Trial #94827, Prostate Cancer, Duarte, CA Trial Information Androgen Deprivation and Localized Radiotherapy to Metastases in Patients with Oligometastatic Hormone - Sensitive Prostate Cancer You have been asked to ...
...deprivation ( depriving the tumor cell of a necessary growth substance—androgen, specifically testosterone ) and localized radiotherapy in terms of shrinking your tumor and delaying the progression (growth) of the cancer. This ...
View Page

2.  Study Posting (2348) Trial #55131, Prostate Cancer, New York, NY
...Trial Information Neoadjuvant/Adjuvant Docetaxel and Estramustine in Combination with Brachytherapy and Three-Dimensional Conformal Radiotherapy Standard treatment for prostate cancer includes radiation therapy and hormone therapy. Radiation therapy uses high ...
...mssm.edu Neoadjuvant/Adjuvant Docetaxel and Estramustine in Combination with Brachytherapy and Three-Dimensional Conformal Radiotherapy Prostate Cancer New York, NY 55131 Clinical Trial Participation If you would like to learn ...
View Page

3.  Study Posting (2246) Trial #140355, Prostate Cancer, Duarte, CA
...III Trial of Short Term Androgen Deprivation with Pelvis Lymph Node or Prostate Bed Only Radiotherapy (SPORT)in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy You have been ...
...III Trial of Short Term Androgen Deprivation with Pelvis Lymph Node or Prostate Bed Only Radiotherapy (SPORT)in Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy ...
View Page

4.  Study Posting (5479) Trial #161924, Non-Small Cell Lung Cancer, Wauwatosa, WI
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Jan DeBartolo Oncology ...
View Page

5.  Study Posting (5479) Trial #161918, Non-Small Cell Lung Cancer, Greenville, SC
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Anna Polan Cancer ...
View Page

6.  Study Posting (5479) Trial #161915, Non-Small Cell Lung Cancer, Charleston, SC
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Deborah McNeal Charleston ...
View Page

7.  Study Posting (5479) Trial #161912, Non-Small Cell Lung Cancer, Woonsocket, RI
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Lisa Furtado Landmark ...
View Page

8.  Study Posting (5479) Trial #161906, Non-Small Cell Lung Cancer, Philadelphia, PA
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Joann Ackler Albert ...
View Page

9.  Study Posting (5479) Trial #161903, Non-Small Cell Lung Cancer, Middletown, OH
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Lisa Frisby Signal ...
View Page

10.  Study Posting (5479) Trial #161900, Non-Small Cell Lung Cancer, Dover, OH
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Carrie Smith Gabrail ...
View Page

11.  Study Posting (5479) Trial #161897, Non-Small Cell Lung Cancer, Canton, OH
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Carrie Smith Gabrail ...
View Page

12.  Study Posting (5479) Trial #161879, Non-Small Cell Lung Cancer, Washington, NC
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Nichole Manning Marion ...
View Page

13.  Study Posting (5479) Trial #161876, Non-Small Cell Lung Cancer, Huntersville, NC
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Lori Lipocky Carolina ...
View Page

14.  Study Posting (5479) Trial #161873, Non-Small Cell Lung Cancer, Charlotte, NC
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Amy Minchin Carolinas ...
View Page

15.  Study Posting (5479) Trial #161888, Non-Small Cell Lung Cancer, Bronx, NY
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Yoko Eng Montefiore ...
View Page

16.  Study Posting (5479) Trial #161885, Non-Small Cell Lung Cancer, Denville, NJ
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Bridget Saggese Cancer ...
View Page

17.  Study Posting (5479) Trial #161882, Non-Small Cell Lung Cancer, Lincoln, NE
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Sue Ortiz Nebraska ...
View Page

18.  Study Posting (5479) Trial #161867, Non-Small Cell Lung Cancer, Southfield, MI
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Jas Grewal Providence ...
View Page

19.  Study Posting (5479) Trial #161864, Non-Small Cell Lung Cancer, Lansing, MI
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Harsha Trivedi Sparrow ...
View Page

20.  Study Posting (5479) Trial #161861, Non-Small Cell Lung Cancer, Detroit, MI
...functions Exclusion Criteria * Squamous histology/cytology * Less than 28 days elapsed from prior treatment with radiotherapy, surgery, or chemotherapy to the time of randomization * Prior isotope therapy, whole pelvic radiotherapy, or radiotherapy to > 25% of bone marrow * Prior docetaxel treatment * Uncontrolled hypertension Tiffany Pearce Henry ...
View Page